More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of their life. Although primarily taken for birth control, ...

For decades, far-right political agendas have targeted contraceptive access, portraying hormonal birth control as unsafe — or ...

The use of combined hormonal contraceptives is linked to a reduced risk for major heart issues in women regardless of ...

This cohort study found associations between hormonal contraceptives and depression risk among first-time moms in the first year postpartum. Researchers found that initiating hormonal contraception ...

Medically reviewed by Mary Choy, PharmD Key Takeaways The vaginal ring (NuvaRing or Annovera) is hormonal birth control that ...

This year, for the first time in the roughly sixty-year history of the birth-control pill in the United States, it can be bought over the counter. You might not know about this development—many people ...

Using hormonal contraception like birth control pills and intrauterine devices can come with side effects, though most doctors say the risk of severe problems is low. But in a new report published in ...

New research has found that depression associated with hormonal contraception use may be a risk factor for developing postpartum depression later on in life. Published in JAMA Psychiatry, the study ...

The long-acting progestogen injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate have been found to adversely affect bone mineral density in adult premenopausal ...

NEW YORK — Gov. Kathy Hochul and New York State Health Commissioner Dr. James McDonald recently signed a standing order authorizing pharmacists to dispense three types of hormonal contraception ...

Please provide your email address to receive an email when new articles are posted on . VTE risk among women varied based on the type of hormonal contraceptive they used. These trends persisted ...

A hormone-free male contraceptive pill called YCT-529 has successfully completed its first human safety trial, marking an ...